批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/07/08 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/12/15 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/04/29 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/03/05 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/04/11 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/12/08 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/07/13 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
2014/06/23 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2014/03/25 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2008/08/20 |
SUPPL-27(补充) |
Approval |
Labeling |
|
|
|
2007/07/21 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
2004/02/20 |
SUPPL-23(补充) |
Approval |
Labeling |
|
|
|
1997/07/08 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/05/12 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/03/22 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/03/17 |
SUPPL-14(补充) |
Approval |
Labeling |
|
|
|
1991/11/06 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/09/30 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/06/12 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1989/09/01 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/01/25 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
1988/06/17 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1985/03/11 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1983/09/29 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:METRONIDAZOLE 剂型/给药途径:INJECTABLE;INJECTION 规格:500MG/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018657 |
001 |
NDA |
FLAGYL I.V. RTU IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
BAXTER HLTHCARE |
018900 |
001 |
NDA |
METRO I.V. IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
Yes |
Yes |
AP |
1983/09/29
|
B BRAUN |
018890 |
002 |
NDA |
METRONIDAZOLE IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
Yes |
Yes |
AP |
1983/11/18
|
HOSPIRA |
078084 |
001 |
ANDA |
METRONIDAZOLE IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
No |
No |
AP |
2008/03/31
|
BAXTER HLTHCARE CORP |
206191 |
001 |
ANDA |
METRONIDAZOLE IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
No |
No |
AP |
2019/02/25
|
INFORLIFE |
212435 |
001 |
ANDA |
METRONIDAZOLE IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
No |
No |
AP |
2020/08/03
|
GLAND PHARMA LTD |
217665 |
001 |
ANDA |
METRONIDAZOLE IN PLASTIC CONTAINER |
METRONIDAZOLE |
INJECTABLE;INJECTION |
500MG/100ML |
Prescription |
No |
No |
AP |
2023/05/24
|
AMNEAL |